Information


The Mental Depression Serotonin Syndrome - Brain Health Insights

By: Robin J. Derry
Submitted: 2007-01-17 16:18:42
Print this article | Tell a friend | For publisher | Social Bookmarking
Rating:
 

Mental health. Our worst fears exposed? Depression, fear and anxiety continue to mark a curse on children and adults around the world. Internal "issues" build, then burst into potentially life destroying anxiety panic attack. It's now wonder that more and more people are focused on brain health issues.

So, how do you determine "normal" brain health, and whether your brain's glands are producing either too much serotonin or not enough?

The Serotonin Depression Link. In the mind-body health matrix, mental and physical operations are intimately connected. Our understanding of this mind-body connection has rapidly expanded due to the world of neuro-science research, where brain health experts theorize that important brain "mood" regulators include natural serotonin and norepinephrine. Meanwhile, these same neuro-scientists theorize that your body utilizes these hormonal regulators as a chemical arbiter for "physical pain".

Create a serotonin deficiency and you'll gradually see the tentacles and growth in mental depression along with physical pain and discomfort.

Too Much Serotonin Versus Low Serotonin - What's Important? Brain chemistry is complex stuff. Further complicating "guidelines" advice is the fact that natural serotonin levels can vary significantly between persons. Here's the generalized every-day-understanding to know about.

* Low Serotonin Levels. Can "show" through a menu of distressed behavior patterns including obsessive compulsive disorder, depression, anxiety panic attacks, drowsy and bulimia food aversion.

* Too Much Serotonin. An imbalance or serotonin overdose creates its own brand of crises, including the potential for fever, headaches, migraine, feel less hungry, coma, brain seizures, damages to your heart and cardiovascular system and in the event of true serotonin syndrome (toxicity) even death.

Technical Stuff To Know - Selective Serotonin Reuptake Inhibitor "Side Effects". Any of the "psycho" drugs including the class of selective serotonin reuptake inhibitor compounds act to increase serotonin across all neural pathways. Results? Side effects can include ongoing anxiety, insomnia, sexual dysfunction, gastrointestinal imbalance, dry mouth, nausea. On one hand, a serotonin norepinephrine increase addresses depression and pain. Taken too far, these therapies trigger nuisance side effects, which left undiagnosed can build into other health risks.

Bottom line? Your body adjusts to medical interventions, creating a "tolerance", so many of the "potential" down-side risks of selective serotonin reuptake inhibitor compounds are relegated to "nuisance" factor for most people.

Will A Serotonin Supplement Work? Yes. Consider that your brain has over 10 billion cells and perhaps 4 million miles of nerve fibers, so you're exhibiting one of the most complex organs ever developed. Even while each of these billions of cells may also have a network of over 25,000 "connections" with other cells, a serotonin supplement can, and will, work its way in between these "connections".

Result? Brain cells will now "talk" differently to each other because receptor sites can be adjusted to slow down or speed-up messages, which we experience as "mood", "thought", "physical pain or pleasure" and so on. Imagine that all of this complex stuff, and whirring action is happening at around 120 mph through your brain's neural network!

Article source: Expert Articles

Most Recent Articles in Depression category

  • Work Stress? It's a State of Mind - By: Sandra Prior
    It may be that events at work conspire against you - but it's how you respond to them that makes all the difference. It all comes down to attitude. Each of our attitudes is like a pebble thrown into the still waters of the pond, creating a ripple effect all around us.
  • What Can Be Done about Depression in Alzheimer's Disease? - By: John Scott
    The article considers whether there is any evidence that Zoloft may assist people who have Alzheimer's Disease and are depressed. It concludes that the limited evidence is quite encouraging.
  • Learning from the past - By: John Scott
    The article looks back to 1994 when the cost of anxiety disorders to the US economy was $65 billion. Because public health care is underfunded, treatments have focused on oral medications as the cheap solution rather than expensive behavioural therapy which has a better chance of a cure.
  • A new study shows insomnia is more persistent - By: John Scott
    The article considers a twenty year study into insomnia which found that sleep loss continued and worsened over time, and that it was often followed by depression.
  • What is the story behind pre-emption? - By: John Scott
    The article visits the thorny legal question of pre-emption in relation to the liability of drug companies. It concludes that the Supreme Court should allow people injured by medications to sue.
  • How do you stay at the top of your league? - By: John Scott
    The article notes that the Neurogen Corp., a biotech company based in Connecticut, has just laid off forty-five staff and raised $30m so that it can afford to pay for the trials to prove the worth of a competitor to Ambien (and three other medications). Is the gamble worth the jobs of forty-five employees?
  • Instead of counting sheep, we should be counting prescriptions - By: John Scott
    The article wonders why insomnia seems to have become an epidemic. Millions of prescriptions a day are written around the world. Perhaps it is the 24/7 lifestyle or that we worry too much. Whatever it is, the world as a whole is suffering from lack of sleep.
  • Should DUI Become DUIA? - By: John Scott
    The articles notes a paper presented in the March meeting of the American Academy of Forensic Science which identified ambien as one of the top ten drugs found in blood samples following arrests for traffic offences. It seems that "sleep driving" may be a new danger to other road users.
  • Prejudice and disability - By: John Scott
    The article reflects on the nature of disability and considers why many for suffer from anxiety and panic attacks fail to complete the course of treatment
  • Effectiveness of Warnings Put out by the FDA and Health Canada - By: John Scott
    The article looks at two decisions in the US courts and some new Canadian research about the effectiveness of warnings put out by the FDA and Health Canada. It seems that the warning about the risk of suicide when taking SSRIs were inadequate but pre-emption prevents a tort claim in the US.